263 related articles for article (PubMed ID: 32760100)
1. Decrease in the prevalence of hepatitis B and D virus infections in an endemic area in Peru 23 years after the introduction of the first pilot vaccination program against hepatitis B.
Cabezas C; Trujillo O; Balbuena J; Peceros FM; Terrazas M; Suárez M; Marin L; Apac J; Ramírez-Soto MC
PLoS One; 2020; 15(8):e0236993. PubMed ID: 32760100
[TBL] [Abstract][Full Text] [Related]
2. [Reduction of HBV and HDV infection in two indigenousmpeoples of Peruvian Amazon after the vaccination against hepatitis B].
Cabezas C; Trujillo O; Balbuena J; Terrazas M; Manrique-de Lara C; Marín L; Ramírez-Soto MC
Salud Publica Mex; 2020; 62(3):237-245. PubMed ID: 32520481
[TBL] [Abstract][Full Text] [Related]
3. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
Amini S; Mahmoodi MF; Andalibi S; Solati AA
J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
[TBL] [Abstract][Full Text] [Related]
4. A comparative epidemiological study of hepatitis B and hepatitis D virus infections in Yanomami and Piaroa Amerindians of Amazonas State, Venezuela.
Duarte MC; Cardona N; Poblete F; González K; García M; Pacheco M; Botto C; Pujol FH; Williams JR
Trop Med Int Health; 2010 Aug; 15(8):924-33. PubMed ID: 20561309
[TBL] [Abstract][Full Text] [Related]
5. [Prevalence of hepatitis B and D serological markers in the Parakanã, Apyterewa Indian Reservation, Pará State, Brazil].
Nunes HM; Monteiro MR; Soares Mdo C
Cad Saude Publica; 2007 Nov; 23(11):2756-66. PubMed ID: 17952269
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of HBV (anti-HBc, HBsAg and anti-HBs) and HDV infections among 9006 women at delivery.
Bart PA; Jacquier P; Zuber PL; Lavanchy D; Frei PC
Liver; 1996 Apr; 16(2):110-6. PubMed ID: 8740844
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of hepatitis B virus and hepatitis D virus in the western Brazilian Amazon.
Viana S; Paraná R; Moreira RC; Compri AP; Macedo V
Am J Trop Med Hyg; 2005 Oct; 73(4):808-14. PubMed ID: 16222030
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence of serological markers of viral hepatitis A, B and delta in apparently healthy schoolchildren of Huanta, Peru].
Cabezas C; Gotuzzo E; Escamilla J; Phillips I
Rev Gastroenterol Peru; 1994; 14(2):123-34. PubMed ID: 7948940
[TBL] [Abstract][Full Text] [Related]
9. [The prevalence of the markers of viral hepatitis B and delta among the population in regions differing in the level of morbidity].
Iashina TL; Favorov MO; Shakhgil'dian IV; Firsova SN; Eraliev AE; Zhukova LD; Reznichenko RG
Vopr Virusol; 1992; 37(4):194-6. PubMed ID: 1471341
[TBL] [Abstract][Full Text] [Related]
10. Seroepidemiology of hepatitis A, B, C, D and E virus infections in the general population of Peru: A cross-sectional study.
Cabezas C; Trujillo O; Gonzales-Vivanco Á; Benites Villafane CM; Balbuena J; Borda-Olivas AO; Suarez-Jara MA; Peceros FM; Ramírez-Soto MC
PLoS One; 2020; 15(6):e0234273. PubMed ID: 32542052
[TBL] [Abstract][Full Text] [Related]
11. Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.
Aghasadeghi MR; Velayati AA; Mamishi S; Nabavi M; Aghakhani A; Bidari-Zerehpoosh F; Haghi Ashtiani MT; Sabeti S; Banifazl M; Azimian-Zavareh F; Motevalli F; Soleymani S; Ramezani A
Arch Virol; 2016 Dec; 161(12):3405-3411. PubMed ID: 27613286
[TBL] [Abstract][Full Text] [Related]
12. The burden and epidemiology of hepatitis B and hepatitis D in Georgia: findings from the national seroprevalence survey.
Kasradze A; Shadaker S; Kuchuloria T; Gamkrelidze A; Nasrullah M; Gvinjilia L; Baliashvili D; Chitadze N; Kodani M; Tejada-Strop A; Drobeniuc J; Hagan L; Morgan J; Imnadze P; Averhoff F
Public Health; 2020 Aug; 185():341-347. PubMed ID: 32738575
[TBL] [Abstract][Full Text] [Related]
13. [Comparative analyze on hepatitis B seroepidemiological surveys among population aged 1-29 years in different epidemic regions of China in 1992 and 2014].
Wang FZ; Zhang GM; Shen LP; Zheng H; Wang F; Miao N; Yuan QL; Sun XJ; Bi SL; Liang XF; Wang HQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):462-468. PubMed ID: 28592086
[No Abstract] [Full Text] [Related]
14. Impact of hepatitis B vaccination among children in Guangdong Province, China.
Xiao J; Zhang J; Wu C; Shao X; Peng G; Peng Z; Ma W; Zhang Y; Zheng H
Int J Infect Dis; 2012 Sep; 16(9):e692-6. PubMed ID: 22795176
[TBL] [Abstract][Full Text] [Related]
15. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
Tsebe KV; Burnett RJ; Hlungwani NP; Sibara MM; Venter PA; Mphahlele MJ
Vaccine; 2001 Jul; 19(28-29):3919-26. PubMed ID: 11427266
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia.
Inoue J; Takahashi M; Nishizawa T; Narantuya L; Sakuma M; Kagawa Y; Shimosegawa T; Okamoto H
J Med Virol; 2005 Jul; 76(3):333-40. PubMed ID: 15902700
[TBL] [Abstract][Full Text] [Related]
17. Continuing Decrease in Hepatitis B Virus Infection 30 Years After Initiation of Infant Vaccination Program in Taiwan.
Ni YH; Chang MH; Jan CF; Hsu HY; Chen HL; Wu JF; Chen DS
Clin Gastroenterol Hepatol; 2016 Sep; 14(9):1324-30. PubMed ID: 27155556
[TBL] [Abstract][Full Text] [Related]
18. Sero-prevalence of hepatitis B virus markers and associated factors among children in Hawassa City, southern Ethiopia.
Argaw B; Mihret A; Aseffa A; Tarekegne A; Hussen S; Wachamo D; Shimelis T; Howe R
BMC Infect Dis; 2020 Jul; 20(1):528. PubMed ID: 32698884
[TBL] [Abstract][Full Text] [Related]
19. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis D virus infection in the Western Brazilian Amazon - far from a vanishing disease.
Braga WS; Castilho Mda C; Borges FG; Leão JR; Martinho AC; Rodrigues IS; Azevedo EP; Barros Júnior GM; Paraná R
Rev Soc Bras Med Trop; 2012 Dec; 45(6):691-5. PubMed ID: 23295870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
